regorafenib

Ukraine

Drugs containing this active substance

  • STIVAR®

    The drug is prescribed to adult patients for the treatment of metastatic colorectal cancer, unresectable or metastatic gastrointestinal stromal tumors (GIST), as well as hepatocellular carcinoma (HCC).

    Form: tablets, film-coated

    Active substance Dosage
    regorafenib 40 mg

    ATC: L01EX05

    Manufacturer: Bayer AG (full-cycle manufacturing (in-bulk production, primary packaging, secondary packaging, quality control, batch release))